Home       Market Dynamics     You and Market     Sector Analysis     Company Insights     AI Investing     About     Contact Us     Login             

Alnylam Pharmaceuticals (ALNY) Stock Price Prediction and News Highlight
Fri. Oct 17, 2025

The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The overall sentiment for Alnylam Pharmaceuticals is positive (overall 1.2, positive 3.1, negative -1.9) on 2025-10-17. The forces of Sentiment towards Fundamentals (2.5), Stock Price Trend (1.8), Option Sentiment (1.5), and Sector Price Trend (0.8) will drive up the price. The forces of Price Level Sentiment (-1), Market Risk Appetite (-1.3), and Valuation Sentiment (-1.5) will drive down the price.

'Buy the dips' is the preferred trading strategy. Hourly SMA 20 trend line is likely to provide a support from any pullbacks. The swing to upside will be significant considering the high positive sentiment forces (3.1).

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale.


Earning Release: 2025-10-30 06:30, EPS: $-2.45, P/E: -196.6

DateAttentionAverage
Attention
PricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Market
Sentiment
ActionFund.News
Sentiment
2025-10-170%      0%      481.67      108      0.12%      0.56%      1.8      0.4      Short      2.5      -1.5     
2025-10-160%      0%      481.07      120      2.3%      0.43%      1.2      0.3      Short      2.9      -1.5     
2025-10-150%      0%      470.27      103      0.19%      0.2%      1      0.1      Short      2.4      -1.5     
2025-10-140%      0%      469.36      109      0.95%      0.31%      0.5      0.1      Short      2.2      -1.5     
2025-10-130%      0%      464.95      97      1.04%      0.37%      0.6      0.2      Short      2.1      -1.5     
2025-10-120%      0%      0.4      0.4      Range      2.1      -1.5     
2025-10-110%      0%      0.4      0.6      Range      3.2      -1.5     
2025-10-100%      0%      460.16      76      0.7%      0.31%      0.4      0.8      Range      3.4      -1.5     
2025-10-090%      0%      456.95      56      1.39%      0.15%      -0.4      0.8      Range      3.4      -1.5     
2025-10-080%      0%      450.68      26      -1.94%      -0.15%      -0.4      0.9      Range      3.4      -1.5     
 
Trend sentiment reflects the price change, and market sentiment scores are calculated from many factors. Sentiment towards fundamentals and news sentiment are extracted from news headline. All sentiment scores are normalized in a -10 - +10 scale.
The price level reaches 100 at Bollinger upper band, and zero at lower band.
Range refers to range trade strategy. In an uptrend, the price will likely bullback after huge advance. As an investor, you may want to wait for the pullback to open long position. As a trader, you may consider tactical short. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. As a trader, you may consider tactical long.

2025-10-17 17:09:07 The performance of the stock may reflect positive analyst opinions and forecasts regarding the company's future potential.
2025-10-17 17:09:07 Alnylam Pharmaceuticals' stock performance can indicate its competitive positioning within the pharmaceutical industry and investor sentiment about its product pipeline.
2025-10-17 17:09:07 The gain in stock price may reflect broader market trends favoring pharmaceutical stocks or biotech investments.
2025-10-17 17:09:07 The article implicitly suggests that the stock price increase may be a result of strong investor confidence and potential investments in the company.
2025-10-17 17:09:07 The article reflects a positive sentiment regarding the stock performance of Alnylam Pharmaceuticals, showcasing a slight gain in its closing price.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA